Literature DB >> 15254872

Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes.

M Fukushima1, M Usami, M Ikeda, Y Nakai, A Taniguchi, T Matsuura, H Suzuki, T Kurose, Y Yamada, Y Seino.   

Abstract

To evaluate the factors causing glucose intolerance in type 2 diabetes in Japan, insulin secretion and insulin sensitivity were compared across the range of glucose tolerance. Subjects were divided into 3 groups: normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and type 2 diabetes (DM) according to the criteria of the World Health Organization (WHO). We examined insulin secretion and insulin sensitivity using fasting blood glucose and insulin levels and 75 g oral glucose tolerance test (OGTT). We used homeostasis model assessment (HOMA) beta-cell and insulinogenic index (30 minutes) to estimate insulin secretion and HOMA-insulin resistance (IR) and insulin sensitivity index (ISI) composite for insulin sensitivity. Although insulin resistance plays an important role in the development of diabetes in many ethnic populations, the differences in insulin sensitivity between NGT and IGT and between IGT and DM are small in Japanese patients. On the other hand, as glucose intolerance increases, insulin secretion decreases most remarkably both between NGT and IGT and between IGT and DM in Japanese patients. Decreasing insulin secretion and decreasing insulin sensitivity both occur in developing type 2 diabetes in Japanese patients, but decreased basal and early-phase insulin secretion had more pronounced contribution to glucose tolerance than the indices of insulin sensitivity. Japanese type 2 diabetic patients are characterized by a larger decrease in insulin secretion and show less attribution of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254872     DOI: 10.1016/j.metabol.2004.02.012

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  71 in total

1.  Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice.

Authors:  Y Takeda; Y Fujita; J Honjo; T Yanagimachi; H Sakagami; Y Takiyama; Y Makino; A Abiko; T J Kieffer; M Haneda
Journal:  Diabetologia       Date:  2011-11-10       Impact factor: 10.122

2.  IFSO-APC consensus statements 2011.

Authors:  Kazunori Kasama; Wilfred Mui; Wei Jei Lee; Muffazal Lakdawala; Takeshi Naitoh; Yosuke Seki; Akira Sasaki; Go Wakabayashi; Iwao Sasaki; Isao Kawamura; Lilian Kow; Harry Frydenberg; Anton Chen; Mahendra Narwaria; Pradeep Chowbey
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

3.  Assessing the impact of cigarette smoking on β-cell function and risk for type 2 diabetes in a non-diabetic Chinese cohort.

Authors:  Cai Chen; Ya-Qin Tu; Ping Yang; Qi-Lin Yu; Shu Zhang; Fei Xiong; Cong-Yi Wang
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

4.  Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the post-World War II birth cohort.

Authors:  Akira Sekikawa; Hirotsugu Ueshima; Takashi Kadowaki; Aiman El-Saed; Tomonori Okamura; Tomoko Takamiya; Atsunori Kashiwagi; Daniel Edmundowicz; Kiyoshi Murata; Kim Sutton-Tyrrell; Hiroshi Maegawa; Rhobert W Evans; Yoshikuni Kita; Lewis H Kuller
Journal:  Am J Epidemiol       Date:  2007-01-22       Impact factor: 4.897

Review 5.  Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions.

Authors:  Kayo Fujita; Masayuki Kaneko; Mamoru Narukawa
Journal:  Clin Drug Investig       Date:  2017-03       Impact factor: 2.859

6.  Association of genetic variants of the α-kinase 1 gene with type 2 diabetes mellitus in a longitudinal population-based genetic epidemiological study.

Authors:  Yoshiji Yamada; Kota Matsui; Ichiro Takeuchi; Mitsutoshi Oguri; Tetsuo Fujimaki
Journal:  Biomed Rep       Date:  2015-03-02

7.  Neurogenic hyperadrenergic orthostatic hypotension: a newly recognized variant of orthostatic hypotension in older adults with elevated norepinephrine (noradrenaline).

Authors:  Philip L Mar; Cyndya A Shibao; Emily M Garland; Bonnie K Black; Italo Biaggioni; André Diedrich; Sachin Y Paranjape; David Robertson; Satish R Raj
Journal:  Clin Sci (Lond)       Date:  2015-07       Impact factor: 6.124

Review 8.  A review of rodent models of type 2 diabetic skeletal fragility.

Authors:  Roberto J Fajardo; Lamya Karim; Virginia I Calley; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

9.  Differences in insulin sensitivity, pancreatic beta cell function and circulating adiponectin across glucose tolerance status in Thai obese and non-obese women.

Authors:  La-Or Chailurkit; Suwannee Chanprasertyothin; Wallaya Jongjaroenprasert; Boonsong Ongphiphadhanakul
Journal:  Endocrine       Date:  2008-04-04       Impact factor: 3.633

10.  Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku study.

Authors:  Akiko Morimoto; Yukako Tatsumi; Kijyo Deura; Shoichi Mizuno; Yuko Ohno; Naomi Miyamatsu; Shaw Watanabe
Journal:  Diabetologia       Date:  2013-05-17       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.